References
- Abramovici D, Friedman S A, Mercer B M, Audibert F, Kao L, Sibai B. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: Does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter. American Journal of Obstetrics and Gynecology 1999; 180: 221–225
- De Boer K, Buller H R, Ten Cate J W, Treffers P E. Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. British Journal of Obstetrics and Gynaecology 1991; 98: 42–47
- Essien A M, Usanga E A, Ayeni O. The normal platelet count and platelet factor 3 availability in some Nigerian population groups. Scandinavian Journal of Haematology 1973; 10: 378–383
- IFCC, Bergman H U, Bowers G N, Jr., Hoerder M, Moss D W. International Federation of Clinical and Laboratory medicine. IFCC method for aspartate aminotransferases. Clinica Chimica Acta 1976; 70: 19–42
- Jendrassik L, Grof P. Simplified photometric method for determination of blood bilirubin. Biochem. Z 1938; 297: 81
- Lewis S M, Bawn B J, Bates L. Practical haematology9th ed. Churchill Livingstone, Edinburgh 2001; 633
- Magann E F, Perry K G, Jr, Meydrech E F, Harris R L, Chauhan S P, Martin J N, Jr. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). American Journal of Obstetrics and Gynecology 1994; 171: 1154–1158
- Martin J N, Jr, Files J C, Blake P G, Norman P H, Martin R W, Hess L W, et al. Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome. American Journal of Obstetrics and Gynecology 1990; 162: 126–137
- Milne F, Redman C, Walker J, Barker P, Bradley J, Cooper C, et al. The preeclampsia community guideline (PRECOG): how to screen for and detect onset of preeclampsia in the community. British Medical Journal 2005; 330: 576–580
- Sibai B M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing. American Journal of Obstetrics and Gynecology 1990; 162: 311–316
- Sibai B M, Ramadan M K, Usta I, Salama M, Mercer B M, Friedman S A. Maternal morbidity in 442 pregnancies with haemolysis, elevated liver enzymes and low platelets. American Journal of Obstetrics and Gynecology 1993; 169: 1000–1006
- Sibai B M, Taslimi M M, El-Nazer A, Amon E, Mabie B C, Ryan G M. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. American Journal of Obstetrics and Gynecology 1986; 155: 501–509
- Thaddeus S, Maine D. Too far to walk. Maternal mortality in context. Social Science and Medicine 1994; 38: 109–110
- Thiagarajah S, Bourgeois F J, Harbert G M, Caudle M R. Thrombocytopaenia in preeclampsia: Associated abnormalities and management principles. American Journal of Obstetrics and Gynecology 1984; 150: 1–7
- Thomas S V. Neurological aspects of eclampsia. Journal of the Neurological Sciences 1998; 155: 37–43
- Tompkins M J, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. American Journal of Obstetrics and Gynecology 1999; 181: 304–309
- Vigil-De Gracia P, García-Cáceres E. Dexamethasone in the post-partum treatment of HELLP syndrome. International Journal of Gynaecology and Obstetrics 1997; 59: 217–221
- Weinstein L. Syndrome of haemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 1982; 142: 159–167
- Yalcin O T, Sener T, Hassa H, Ozalp S, Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. International Journal of Gynaecology and Obstetrics 1998; 61: 141–148